New lab licenses strengthen nationwide access to CNS oncology diagnostics Plus Therapeutics (NASDAQ: PSTV) has announced a major regulatory and commercialization milestone with the expansion of laboratory licenses for its CNSide® Cerebrospinal Fluid (CSF) Tumor Cell...

Expanding operational and regulatory expertise to support commercialization and growth Plus Therapeutics (NASDAQ: PSTV) today announced two key leadership additions to CNSide Diagnostics, its wholly-owned subsidiary, further strengthening the company’s operational...

Strengthening CNS oncology diagnostics at the heart of America’s largest medical ecosystem CNSide Diagnostics, a subsidiary of Plus Therapeutics (NASDAQ: PSTV), has officially expanded into Levit Green, a premier life sciences innovation campus developed by Hines in...

In the evolving landscape of central nervous system (CNS) oncology, the integration of advanced diagnostic technologies with precision therapeutic innovation is reshaping how clinicians detect, monitor, and manage complex CNS cancers. At CNSide Diagnostics, we are...

Accurately detecting and quantifying tumor cells in cerebrospinal fluid (CSF) is essential for diagnosing, monitoring, and managing central nervous system (CNS) malignancies—particularly leptomeningeal metastases (LM) and other aggressive cancers that spread to the...

CNSide Diagnostics is pleased to announce a major milestone in expanding patient access to advanced CNS cancer diagnostics. Humana (NYSE: HUM)—one of the nation’s largest health insurers—has entered into a national agreement with Plus Therapeutics, providing coverage...

The Society for Neuro-Oncology (SNO) and WFNOS Annual Meeting is one of the most important gatherings of clinicians, researchers, and innovators working to improve outcomes for patients with central nervous system (CNS) cancers....

Each year, approximately 110,000 people in the United States are affected by leptomeningeal metastases (LM) — a devastating complication of advanced cancers such as breast, lung, and melanoma. Despite its prevalence, treatment options remain limited, costly, and often...

Our CNSide Diagnostics lab team brought some Halloween fun to our new Houston facility at Levit Green — a creative and spirited way to celebrate as we continue to build momentum in our new space! Beyond the costumes and candy, this moment reflects a larger milestone...